2,271 press releases in English indexed under biotech & pharma.
Two abstracts on long-term follow-up data of AHB-137 treatment for chronic hepatitis B have been selected for late-breaking oral presentations at The Liver Meeting® 2026. SAN FRANCISCO, Oct. 7, 2026 -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together,...
SHANGHAI, Oct. 7, 2026 -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received a Gold medal from EcoVadis for the third consecutive year, reflecting the Company's consistent commitment to...
As dentistry moves toward regeneration, artificial intelligence, and biologic preservation, the Beverly Hills dentist behind the concept is asking whether progress may increasingly be defined by what clinicians can preserve, not only by what they can repair or replace. As dentistry moves toward regeneration, artificial intelligence, and biologic preservation, the Beverly Hills dentist behind the concept is asking whether progress may increasingly be defined by what clinicians can preserve, not only by what they can repair or replace.
ALISO VIEJO, Calif., October 07, 2026--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today positive topline results from a long-term Phase 3 extension study (GLK-202-03) evaluating the durability, visual outcomes, and safety of Epioxa®, the company's groundbreaking epi-on corneal cross-linking therapy for the treatment of keratoconus, a sigh
Dr. Yanjun Ma helps uncover genetic and epigenetic clues to extraordinary longevity and cancer resistance in 194-year-old giant tortoise NASHVILLE, Tenn., Oct. 7, 2026 -- Tennessee Oncology is contributing to groundbreaking research into one of biology's most enduring...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options
Company announcement – No. 54 / 2026
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted two Breakthrough Therapy Designations (BTDs) for...
Lipocine Inc. (NASDAQ: LPCN ), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that, through Lipocine's licensing partner Verity Pharmaceuticals Inc (Verity Pharma), Health Canada has approved TLANDO® (testosterone undecanoate) capsules for testosterone replacement therapy in adult males for the conditions associated with a deficiency or abse
SAN FRANCISCO, Oct. 7, 2026 -- Hagens Berman Sobol Shapiro LLP, a national shareholder rights firm, notifies investors in Aardvark Therapeutics, Inc. (NASDAQ: $AARD) of a pending securities class action lawsuit. Investors who purchased or acquired Aardvark common stock...
Potentially accelerates development, assessment, and review for approval by FDA
LEHI, Utah, Oct. 7, 2026 -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting inflammasome-driven disease biology, today announced that the Company plans to participate in the 6th Annual Needham Private Biotech...